SEC adds whistleblower retaliation charges against ex-NS8 CEO
By 
Kyle Brasseur2022-12-01T21:11:00
The former chief executive officer of cyber-fraud prevention company NS8 now faces charges of impeding and retaliating against a whistleblower following an amended complaint from the Securities and Exchange Commission (SEC).
Adam Rogas, a co-founder of NS8 who also served as the company’s former chief financial officer, was sentenced to five years in prison last month by a federal judge after pleading guilty to defrauding investors of more than $100 million. He was ordered to forfeit more than $17.5 million.
Despite the steep penalties, Rogas still faces potential discipline from the SEC, which also accused him of fraud in a complaint filed in September 2020.
Related articles
-
News BriefBipartisan bill strengthening SEC whistleblower program reintroduced
Sens. Chuck Grassley (R-Iowa) and Elizabeth Warren (D-Mass.) revived a whistleblower protection bill aimed at shielding whistleblowers from retaliation and cutting down on the time it takes to receive an award from the Securities and Exchange Commission.
-
ArticleEx-CEO at NS8 imprisoned 5 years, to forfeit $17.5M for fabricating revenue
The co-founder of NS8, a cyber-fraud prevention company, was sentenced to five years in prison and ordered to forfeit $17.5 million for defrauding investors of more than $100 million, the Department of Justice announced.
-
ArticleFormer tech exec to pay $97K for impeding SEC whistleblower
David Hansen, co-founder of Las Vegas-based software company NS8, agreed to pay $97,523 to settle charges from the Securities and Exchange Commission that he impeded a whistleblower’s attempt to communicate with the agency about a securities law violation.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”